Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Year range
1.
Journal of Zhejiang University. Science. B ; (12): 1-18, 2022.
Article in English | WPRIM | ID: wpr-929036

ABSTRACT

With the recent upsurge of studies in the field of microbiology, we have learned more about the complexity of the gastrointestinal microecosystem. More than 30 genera and 1000 species of gastrointestinal microflora have been found. The structure of the normal microflora is relatively stable, and is in an interdependent and restricted dynamic equilibrium with the body. In recent years, studies have shown that there is a potential relationship between gastrointestinal microflora imbalance and gastric cancer (GC) and precancerous lesions. So, restoring the balance of gastrointestinal microflora is of great significance. Moreover, intervention in gastric premalignant condition (GPC), also known as precancerous lesion of gastric cancer (PLGC), has been the focus of current clinical studies. The holistic view of traditional Chinese medicine (TCM) is consistent with the microecology concept, and oral TCM can play a two-way regulatory role directly with the microflora in the digestive tract, restoring the homeostasis of gastrointestinal microflora to prevent canceration. However, large gaps in knowledge remain to be addressed. This review aims to provide new ideas and a reference for clinical practice.


Subject(s)
Humans , Drugs, Chinese Herbal/therapeutic use , Gastrointestinal Microbiome , Medicine, Chinese Traditional , Precancerous Conditions/pathology , Stomach Neoplasms/pathology
2.
Chinese Journal of Experimental Traditional Medical Formulae ; (24): 233-239, 2021.
Article in Chinese | WPRIM | ID: wpr-905854

ABSTRACT

Gastric cancer is one of the most common malignant tumors in the digestive system, and precancerous lesion of gastric cancer (PLGC) represents a long-term stage in the process of malignant development of normal gastric mucosa into gastric cancer. Gastric cancer and precancerous lesions are difficult to cure clinically, leaving poor prognosis and a serious negative impact on the quality of daily life of patients. In recent years, studies on cell autophagy have been at the forefront of the natural life science. Regulating autophagy to treat precancerous lesions and prevent gastric cancer has become nowadays a hot topic. Autophagy is a process in which cells enclose some redundant or damaged cytoplasm, proteins and organelles to form autophagosomes, and bind to lysosomes to degrade the contents. Autophagy has bidirectional effect on different cells and different stages of the same cell. Autophagy at a lower level can kill cancer cells, while autophagy can promote the growth and proliferation of cancer cells under stress conditions such as hypoxia, hunger and infection, or when autophagy clears damaged proteins in cells and organelle function is abnormal. Traditional Chinese medicine(TCM), which has low toxicity and easy acceptance by patients, has a positive effect on the treatment of gastric cancer and PLGC. At present, studies on the prevention and treatment of gastric cancer and PLGC by TCM have been carried out in depth with cell autophagy as the breakthrough point. More and more research results have confirmed that TCM can regulate the autophagy process of gastric cancer cells and play an anti-tumor role by interfering with various autophagy related genes, signal pathways and organelles. This paper summarizes the studies on the regulation of cell autophagy by TCM in the treatment of gastric cancer and precancerous lesions, so as to provide references for future studies on the regulation of autophagy by TCM.

3.
China Journal of Chinese Materia Medica ; (24): 4089-4095, 2021.
Article in Chinese | WPRIM | ID: wpr-888066

ABSTRACT

Gastric cancer(GC), one of the most common malignancies worldwide, seriously threatens human health due to its high morbidity and mortality. Precancerous lesion of gastric cancer(PLGC) is a critical stage for preventing the occurrence of gastric cancer, and PLGC therapy has frequently been investigated in clinical research. Exploring the proper animal modeling methods is necessary since animal experiment acts as the main avenue of the research on GC treatment. At present, N-methyl-N'-nitro-N-nitroso-guanidine(MNNG) serves as a common chemical inducer for the rat model of GC and PLGC. In this study, MNNG-based methods for modeling PLGC rats in related papers were summarized, and the applications and effects of these methods were demonstrated by examples. Additionally, the advantages, disadvantages, and precautions of various modeling methods were briefly reviewed, and the experience of this research group in exploring modeling methods was shared. This study is expected to provide a reference for the establishment of MNNG-induced PLGC animal model, and a model support for the following studies on PLGC.


Subject(s)
Animals , Rats , Gastric Mucosa , Methylnitronitrosoguanidine/toxicity , Precancerous Conditions/chemically induced , Stomach Neoplasms/drug therapy
4.
China Pharmacy ; (12): 3433-3436, 2019.
Article in Chinese | WPRIM | ID: wpr-817409

ABSTRACT

OBJECTIVE: To provide reference for clinical treatment of precancerous lesions of gastric cancer. METHODS: A total of 685 patients with precancerous lesions of gastric cancer were selected from our hospital during Jan.-Dec. 2018. Totally 455 patients in treatment group received individualized TCM therapy according to syndrome differentiation, 7 days as a course, 4 courses in total; another 230 patients in control group received Folic acid tablets, 5 mg, tid, for 2 months. The changes of pepsinogen ratio (PGⅠ/PGⅡ), gastrin-17 (G-17) and Helicobacter pylori (Hp)before and after treatment, and the occurrence of ADR were compared between 2 groups. RESULTS: After treatment, total response rate of treatment group was 90.3%, which was significantly higher than 68.6% of control group. PGⅠ/PGⅡ of treatment group were increased significantly, which was significantly higher than control group; G-17 levels of 2 groups were decreased significantly (P<0.05); there was no statistical significance in Hp level between 2 groups before and after treatment (P>0.05). There was no statistical significance in the incidence of ADR between 2 groups(P>0.05). CONCLUSIONS: Chinese medicine syndrome differentiation individual therapy can significantly delay the development of precancerous lesions of gastric cancer, and has good safety.

5.
Journal of Xi'an Jiaotong University(Medical Sciences) ; (6): 597-601,608, 2018.
Article in Chinese | WPRIM | ID: wpr-698275

ABSTRACT

Objective To observe the curative effect of Fuzhengxiaojia decoction on precancerous lesion of gastric cancer (PLGC).Methods We randomly divided 44 patients with PLGC in our hospital into control group (n=22)and treatment group (n=22).The control group was given 4 Weifuchun tablets each time and three times per day and while the treatment group was given one Fuzhengxiaojia decoction of 400 mL besides the medication of the control group.They were treated for two courses,one course lasting for one month.Results Superoxide dismutase (SOD),malondialdehyde (MDA),glutathione peroxidase (GSH-Px),IgG,IgM and IgA in the two groups had no significant differences before treatment (P>0.05).After treatment,compared with those in the control group,SOD (t=2.144,P=0.044)and GSH-Px (t=2.322,P=0.030)increased,while MDA(t=3.096, P=0.005),IgG(t=2.421,P=0.025),IgM(t=3.377,P=0.003)and IgA (t=2.521,P=0.020)decreased. The main symptom scores in the two groups did not significantly differ before treatment (P<0.05).After treatment, compared with those in the control group,the scores for main symptoms like reduced food intake (t=3.924,P<0.001),stomach noise (t=4.161,P<0.001)and gastric or hypochondriac swelling (t=2.881,P<0.009) decreased in the treatment group.The rate of effective cases was higher than that in the control group (χ2=4.539, P=0.033).Conclusion The effect of Weifuchun combined with Fuzhengxiaojia prescriptions in treating PLGC is better than Weifuchun alone,which is related to improving redox and immunoglobulin.

SELECTION OF CITATIONS
SEARCH DETAIL